The U.S. FDA filed a Complete Response Letter (CRL) for the supplemental Biologics License Application for Darzalex Faspro, (daratumumab & hyaluronidase-fihj) which is involved in a quadruplet regimen ...

The White House announced its plan for tariffs on imports from the European Union (EU). In a joint statement, 1 the White House and the EU announced the details of what is being called a framework for ...

The agreement values Mural Oncology at up to $36.2 million, with shareholders set to receive a base cash payment and potential additional consideration tied to closing net cash.

FDA Clinical Hold: BiomX’s Phase IIb trial of BX004 for cystic fibrosis is temporarily paused due to questions about the third-party nebulizer device, while the drug itself remains cleared for ...

Strategic Collaboration: Skyhawk Therapeutics partners with Merck KGaA to leverage the SkySTAR platform to discover RNA-targeting small molecules for neurological disorders. Pipeline Expansion: The ...

Novo Nordisk reduces Ozempic's price to $499/month for self-paying patients, enhancing access to essential diabetes treatment and ensuring patient safety.

Natalie Bickford, chief people officer at Sanofi, reveals how she approaches the employee experience, which ultimately influences employee retention, and discusses the importance of a corporate DE&I ...

Vor Bio appoints Dallan Murray as chief commercial officer, leveraging his extensive experience to drive commercialization and growth strategies for innovative therapies.

EVP, head of regulatory affairs, Astellas Pharma Inc.

Pharmaceutical Executive delivers strategic insights for pharma leaders, covering commercialization, market access, R&D, and leadership to drive success.

Pharmaceutical Executive delivers strategic insights for pharma leaders, covering commercialization, market access, R&D, and leadership to drive success.

Sadik Kassim is chief technology officer, Genomic Medicines for the Life Sciences companies at Danaher Corporation, which include Aldevron, Integrated DNA Technologies (IDT), SCIEX, Beckman Coulter ...